National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
In English | En español
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 Display for Print  New Search
 
Results: 1 -7 of 7         results per page
 View Search Criteria | Help With Results
           

1.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Active
18 and over
Pharmaceutical / Industry
M06-880
NCT00517790


2.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Active
18 and over
Pharmaceutical / Industry
M06-879
NCT00517920


3.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Active
Over 18
Pharmaceutical / Industry
M10-265
EudraCT 2007-005949-38, NCT00645177


4.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Approved-not yet active
Over 18
Pharmaceutical / Industry
M10-300
EudraCT: 2007-007081-38, NCT00707889


5.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Active
18 and over
Pharmaceutical / Industry
M10-301
NCT00716534


6.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase I
Treatment
Approved-not yet active
20 to 75
Pharmaceutical / Industry
M10-227
NCT00718380


7.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase I
Biomarker/Laboratory analysis, Treatment
Approved-not yet active
18 and over
Pharmaceutical / Industry
M10-384
NCT00733187

   
  Display for Print   New Search

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov